CAI Q4 2014 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

Q4 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$59M+7.8% YoY

Gross Profit

$38M65.4% margin

Operating Income

$25M42.9% margin

Net Income

$16M27.5% margin

EPS (Diluted)

$0.76

QoQ Revenue Growth

-0.7%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

-$46M

Stock-Based Comp.

$521,000

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.4B

Stockholders' Equity

$442M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$55M	+7.8%
Gross Profit	$38M	$36M	+5.4%
Operating Income	$25M	$25M	+0.5%
Net Income	$16M	$16M	+3.7%